Effectiveness and Adherence in Trials of Oral and Topical Tenofovir-Based Prevention

Trials of oral and topical tenofovir-based PrEP show that these strategies reduce risk of HIV inection if they are used correctly and consistently. Higher adherence is directly linked to greater levels of protection.